Machine learning prediction of HER2-low expression in breast cancers based on hematoxylin–eosin-stained slides

被引：0
|
作者：
Jun Du [1 ]
Jun Shi [2 ]
Dongdong Sun [3 ]
Yifei Wang [4 ]
Guanfeng Liu [4 ]
Jingru Chen [5 ]
Wei Wang [5 ]
Wenchao Zhou [1 ]
Yushan Zheng [2 ]
Haibo Wu [2 ]
机构：
[1] University of Science and Technology of China,Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine
[2] University of Science and Technology of China,Intelligent Pathology Institute, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine
[3] Hefei University of Technology,School of Software
[4] Hefei University of Technology,School of Computer Science and Information Engineering
[5] University of Science and Technology of China,School of Life Sciences, Division of Life Sciences and Medicine
[6] Beihang University,School of Engineering Medicine, Beijing Advanced Innovation Center on Biomedical Engineering
[7] University of Science and Technology of China,Department of Pathology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine
来源：
Breast Cancer Research | / 27卷 / 1期
关键词：
Breast cancer; Machine learning; Prediction; Hematoxylin–eosin; HER2;
D O I：
10.1186/s13058-025-01998-8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Multiparametric MRI Radiomics for the Identification of HER2-Low Breast Cancers Response
    Ramtohul, Toulsie
    RADIOLOGY, 2024, 310 (01) : 1 - 2
  • [42] Deep Learning-Based Stratification of Gastric Cancer Patients from Hematoxylin and Eosin-Stained Whole Slide Images by Predicting Molecular Features for Immunotherapy Response
    Wei, Zheng
    Zhao, Xu
    Chen, Jing
    Sun, Qiuyan
    Wang, Zeyang
    Wang, Yanli
    Ye, Zhiyi
    Yuan, Yuan
    Sun, Liping
    Jing, Jingjing
    AMERICAN JOURNAL OF PATHOLOGY, 2023, 193 (10): : 1517 - 1527
  • [43] A Comparison of the Biological Profiles of HER2-Low, HER2-Amplified and HER2-Zero Breast Cancers
    Farshid, Gelareh
    Pradhan, Malcolm
    LABORATORY INVESTIGATION, 2023, 103 (03) : S127 - S129
  • [44] The Dynamic of HER2-low Expression during Breast Cancer Progression
    Anderson, Sarah
    Bartow, Brooke
    Huang, Xiao
    Wei, Shi
    LABORATORY INVESTIGATION, 2023, 103 (03) : S89 - S89
  • [45] The dynamics of HER2-low expression during breast cancer progression
    Anderson, Sarah
    Bartow, Brooke Baxter
    Siegal, Gene P.
    Huang, Xiao
    Wei, Shi
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (03) : 437 - 446
  • [46] The dynamics of HER2-low expression during breast cancer progression
    Sarah Anderson
    Brooke Baxter Bartow
    Gene P. Siegal
    Xiao Huang
    Shi Wei
    Breast Cancer Research and Treatment, 2023, 201 : 437 - 446
  • [47] Deep learning-based approach to predict multiple genetic mutations in colorectal and lung cancer tissues using hematoxylin and eosin-stained whole-slide images
    Konishi, Teppei
    Grynkiewicz, Mateusz
    Saito, Keita
    Kobayashi, Takuma
    Goto, Akiteru
    Umakoshi, Michinobu
    Iwata, Takashi
    Nishio, Hiroshi
    Katoh, Yuki
    Fujita, Tomonobu
    Matsui, Tomoya
    Sugawara, Masaki
    Sano, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] ERBB2 mRNA expression in HER2-low breast cancer
    Teng, X.
    Li, X.
    Xu, S.
    Zhang, J.
    Bai, Y.
    Ba, X.
    Wu, Z.
    Liu, S.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S93 - S93
  • [49] Ultrasound-based radiomics nomogram for predicting HER2-low expression breast cancer
    Zhang, Xueling
    Wu, Shaoyou
    Zu, Xiao
    Li, Xiaojing
    Zhang, Qing
    Ren, Yongzhen
    Qian, Xiaoqin
    Tong, Shan
    Li, Hongbo
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [50] Study of HER2-low expression in triple-negative breast cancer
    Trung, T. Tran
    Ngoc, A. Duong Thi
    Van, T. Nguyen
    Van, T. Ta
    BREAST, 2025, 80
12345